90 related articles for article (PubMed ID: 4836406)
1. Chemical conversion of the psychotomimetic amine 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane to 5-hydroxy-2,6-dimethylindole.
Zweig JS; Castagnoli N
J Med Chem; 1974 Jul; 17(7):747-9. PubMed ID: 4836406
[No Abstract] [Full Text] [Related]
2. [Studies on hallucinogens. IV. Synthesis of 2,5-dimethoxy-4-methylamphetamine (STP) (author's transl)].
Ono M; Shimamine M; Takahashi K
Eisei Shikenjo Hokoku; 1973; 91(0):41-44. PubMed ID: 4800136
[No Abstract] [Full Text] [Related]
3. In vitro O-demethylation of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.
Zweig JS; Castagnoli N
J Med Chem; 1977 Mar; 20(3):414-21. PubMed ID: 845874
[TBL] [Abstract][Full Text] [Related]
4. Substituent branching in phenethylamine-type hallucinogens: a comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane.
Oberlender RA; Kothari PJ; Nichols DE; Zabik JE
J Med Chem; 1984 Jun; 27(6):788-92. PubMed ID: 6737421
[TBL] [Abstract][Full Text] [Related]
5. Potential psychotomimetics. 2. Rigid analogs of 2,5-dimethoxy-4-methylphenylisopropylamine (DOM, STP).
Nichols DE; Barfknecht CF; Long JP; Standridge RT; Howell HG; Partyka RA; Dyer DC
J Med Chem; 1974 Feb; 17(2):161-6. PubMed ID: 4809251
[No Abstract] [Full Text] [Related]
6. Metabolic O-demethylation of the psychotomimetic amine 1-(2, 5-dimetroxy-4-methylphenyl)-2-aminopropane.
Zwieg JS; Castagnoli N
Psychopharmacol Commun; 1975; 1(4):359-71. PubMed ID: 1224005
[TBL] [Abstract][Full Text] [Related]
7. In vitro stereoselective metabolism of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane. An apparent enantiomeric interaction.
McGraw NP; Callery SC; Castagnoli N
J Med Chem; 1977 Feb; 20(2):185-9. PubMed ID: 836489
[TBL] [Abstract][Full Text] [Related]
8. Stereochemical aspects and metabolite formation in the in vivo metabolism of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane.
Matin SB; Callery PS; Zweig JS; O'Brien A; Rapoport R; Castagnoli N
J Med Chem; 1974 Aug; 17(8):877-82. PubMed ID: 4845381
[No Abstract] [Full Text] [Related]
9. Monomethylthio analogues of 1-(2,4,5-trimethoxyphenyl)-2-aminopropane.
Jacob P; Anderson G; Meshul CK; Shulgin AT; Castagnoli N
J Med Chem; 1977 Oct; 20(10):1235-9. PubMed ID: 903913
[TBL] [Abstract][Full Text] [Related]
10. Studies on chiral interactions of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane and the corresponding N-hydroxy metabolites with cytochrome P-450.
McGraw NP; Castagnoli N
J Med Chem; 1981 Mar; 24(3):299-304. PubMed ID: 7265116
[TBL] [Abstract][Full Text] [Related]
11. Isomeric cyclopropyl ring-methylated homologues of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, an hallucinogen analogue.
Jacob JN; Nichols DE
J Med Chem; 1982 May; 25(5):526-30. PubMed ID: 7086838
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the identification of psychotropic substances. VI. Preparation and various analytical data of reference standards of some hallucinogens, 2,5-dimethoxy-4-methylamphetamine (STP), 2,5-dimethoxy-4-bromoamphetamine (DOB) and 2,5-dimethoxy-4-ethylamphetamine (DOET)].
Shimamine M; Takahashi K; Nakahara Y
Eisei Shikenjo Hokoku; 1989; (107):113-9. PubMed ID: 2636911
[TBL] [Abstract][Full Text] [Related]
13. Chemical and biological studies of 1-(2,5-dihydroxy-4-methylphenyl)-2-aminopropane, an analogue of 6-hydroxydopamine.
Jacob P; Kline T; Castagnoli N
J Med Chem; 1979 Jun; 22(6):662-71. PubMed ID: 458821
[TBL] [Abstract][Full Text] [Related]
14. N-Hydroxylation of 1-(2,5-demethoxy-4-methylphenyl)-2-aminopropane by rabbit liver microsomes.
Gal J; Gruenke LD; Castagnoli N
J Med Chem; 1975 Jul; 18(7):683-8. PubMed ID: 1151987
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM
J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships in psychotomimetic phenylalkylamines.
Aldous FA; Barrass BC; Brewster K; Buxton DA; Green DM; Pinder RM; Rich P; Skeels M; Tutt KJ
J Med Chem; 1974 Oct; 17(10):1100-11. PubMed ID: 4418757
[No Abstract] [Full Text] [Related]
17. Phenylalkylamines with potential psychotherapeutic utility. 2. Nuclear substituted 2-amino-1-phenylbutanes.
Standridge RT; Howell HG; Tilson HA; Chamberlain JH; Holava HM; Gylys JA; Partyka RA; Shulgin AT
J Med Chem; 1980 Feb; 23(2):154-62. PubMed ID: 7359529
[TBL] [Abstract][Full Text] [Related]
18. Resolution and absolute configuration of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, a potent hallucinogen analogue.
Nichols DE; Woodard R; Hathaway BA; Lowy MT; Yom KW
J Med Chem; 1979 Apr; 22(4):458-60. PubMed ID: 430485
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and gross behavioral effects of amphetamine, 2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM) and 2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) in the conscious dog.
Buyniski JP; Smith ML; Bierwagen ME
Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):213-21. PubMed ID: 4859236
[No Abstract] [Full Text] [Related]
20. A reevaluation of psychotomimetic amphetamine derivatives in humans.
Cassels BK; Gómez-Jeria JS
J Psychoactive Drugs; 1985; 17(2):129-30. PubMed ID: 4020537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
